NCT00504205View on ClinicalTrials.gov

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

March 31, 2010

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

multitargeted receptor tyrosine kinase inhibitor MP470

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

positron emission tomography

Trial Locations (2)

78229

South Texas Accelerated Research Therapeutics, San Antonio

85258-4512

Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Scottsdale

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY